[Overexpression of EZH2 is a marker of advanced and metastatic disease in many solid tumors, including prostate and breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE